RecruitingNot ApplicableNCT07093788

Super High-pressure Balloon Versus Intravascular Lithotripsy to Prepare Severely Calcified Coronary Lesions

Super High-pressure Balloon Versus Intravascular Lithotripsy to Prepare Severely Calcified Coronary Lesions: a Randomized Controlled Trial (Shape)


Sponsor

Nanjing First Hospital, Nanjing Medical University

Enrollment

78 participants

Start Date

Sep 1, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

this trial aimed to evaluate the stent expansion through intravascular imaging (optical coherence tomography (OCT) \& intravascular ultrasound (IVUS)) among individuals underwent different preparation techniques ,then comparing the efficacy and safety of super high-pressure balloon to IVL in severely calcified lesions


Eligibility

Min Age: 18 YearsMax Age: 80 Years

Inclusion Criteria9

  • Age \> 18 years and \< 80 years
  • Presented as asymptomatic angina, stable angina, unstable angina, prior myocardial infarction (MI), or non-ST-elevation myocardial infarction (NSTEMI).
  • Have an indication for drug-eluting stent (DES) implantation
  • Denovo coronary artery calcified lesions
  • Target lesion diameter stenosis ≥ 70%, or target lesion diameter stenosis between ≥ 50% and \< 70%, accompanied by evidence of myocardial ischemia(such as fractional flow reserve (FFR) ≤ 0.80 or minimal lumen area (MLA) ≤ 4.0 mm²).
  • Reference vessel diameter of the target vessel between 2.5 mm - 4.5 mm
  • Maximum calcium arc within the lesion ≥ 270⁰ assessed by optical coherence tomography (OCT) or intravascular ultrasound (IVUS)
  • Unsatisfactory lesion preparation with non-compliant balloon, defined as baseline diameter stenosis reduction of \< 30% under maximal inflation pressure.
  • Provision of written informed consent

Exclusion Criteria8

  • Presented as acute ST-segment elevation myocardial infarction (STEMI), cardiogenic shock and multiple organ failure
  • Presented as severe contrast agent allergy
  • Intolerant to dual antiplatelet therapy (DAPT) and/or anticoagulation therapy
  • Presented as active phase of autoimmune disease
  • Calcified nodules or eccentric calcification lesions
  • Failure to reach the target lesion with guidewires or catheters
  • Complex coronary bifurcation lesions
  • Target vessel thrombosis or aneurysm within 10 mm of the target lesion

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEsuper high-pressure balloon

preparation strategy for calcified lesions after unsatisfactory dilation

DEVICEintravascular lithotripsy (IVL)

preparation strategy for calcified lesions after unsatisfactory dilation


Locations(3)

Lianyungang First People's Hospital

Lianyungang, Jiangsu, China

Nanjing First Hospital

Nanjing, Jiangsu, China

Yixing People's Hospital

Yixing, Jiangsu, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07093788


Related Trials